Symptoms of depression and survival experience among three samples of smokers trying to quit.

Niaura, Raymond; Britt, Dana M.; Shadel, William G.; Goldstein, Michael R.; Abrams, David B.; Brown, Richard A.

doi:10.1037/0893-164x.15.1.13

Cited by 193 publications

(158 citation statements)

References 25 publications

Supporting

Mentioning

137

Contrasting

Unclassified

Order By: Relevance

“…Thus, it may be tempting to ascribe most of the differences noted above to depression, because it is well documented that both those with diabetes and smokers in general are more likely to report depression, and that smokers who are depressed have more diffi culty quitting. [28][29][30][31][32] Our question, however, is not a validated way to identify clinical depression. Unlike Ciechanowski et al, 33 who found depression severity was associated with poorer adherence to diabetic regimens, we could fi nd no clear relationship between these reports of often feeling depressed and either diabetes self-care practices or physical activity levels.…”

Section: Discussionmentioning

confidence: 99%

Diabetic Patients Who Smoke: Are They Different?

Solberg

Desai²,

O’Connor³

et al. 2004

The Annals of Family Medicine

View full text Add to dashboard Cite

BACKGROUND We wanted to identify differences between diabetic patients who smoke and those who do not smoke to design more effective strategies to improve their diabetes care and encourage smoking cessation.METHODS A random sample of adult health plan members with diabetes were mailed a survey questionnaire, with telephone follow-up, asking about their attitudes and behaviors regarding diabetes care and smoking. Among the 1,352 respondents (response rate 82.4%), we found 188 current smokers whose answers we compared with those of 1,264 nonsmokers, with statistical adjustment for demographic characteristics and duration of diabetes. RESULTSSmokers with diabetes were more likely to report fair or poor health (odds ratio [OR] = 1.5, P = .03) and often feeling depressed (OR = 1.7, P = .004). Relative to nonsmokers, smokers had lower rates of checking blood glucose levels, were less physically active, and had fewer diabetes care visits, glycated hemoglobin (A 1c ) tests, foot examinations, eye examinations, and dental checkups (P ≤.01). Smokers also reported receiving and desiring less support from family and friends for specifi c diabetic self-management activities and had lower readiness to quit smoking than has been observed in other population groups.CONCLUSIONS Clinicians should be aware that diabetic patients who smoke are more likely to report often feeling depressed and, even after adjusting for depression, are less likely to be active in self-care or to comply with diabetes care recommendations. Diabetic patients who smoke are special clinical challenges and are likely to require more creative and consistent clinical interventions and support. INTRODUCTIONS moking has long been known to worsen the prognosis of patients with diabetes. Mulhauser' s literature review in 1990 1 concluded that the frequency of smoking in adults with diabetes was comparable to that in the general population and that smoking is a major risk factor for both macrovascular and microvascular complications. Subsequent systematic reviews have strengthened these conclusions while adding evidence that smoking increases insulin resistance, worsens diabetes control, and may even induce the disease.2,3 Many cross-sectional and prospective studies of patients who have diabetes also show that cardiovascular and all-cause mortality is higher in those who smoke than in those who do not smoke. [4][5][6][7] Thus, the 1 in 5 persons with diabetes who also smoke represent a particularly important target for intervention, both by clinicians and by policy makers in health plans and public health.Despite this information, and despite strong evidence that clinician support of smoking cessation is effective for smokers among the general population and those with diabetes, [8][9][10] only 58% of patients with diabetes who smoke reported that a physician had ever advised them to stop or cut down on their smoking. In the past, many diabetes care specialists and some professional organizations have concentrated largely on glucose-oriented diabetes ca...

show abstract

Section: Discussionmentioning

confidence: 99%

Diabetic Patients Who Smoke: Are They Different?

Solberg

Desai²,

O’Connor³

et al. 2004

The Annals of Family Medicine

View full text Add to dashboard Cite

show abstract

“…Because mild levels of depressive symptomatology have been associated with a resumption of smoking, independent of nicotine dependence (33), depressive symptoms also may decrease a woman's motivation to remain abstinent postpartum. Thus, both changes in mood and concerns about body shape and weight may play a role in women's attitudes toward smoking during the postpartum period (34).…”

Section: Introductionmentioning

confidence: 99%

Weight concerns affect motivation to remain abstinent from smoking postpartum

Levine¹,

Marcus²,

Kalarchian³

et al. 2006

ann. behav. med.

View full text Add to dashboard Cite

show abstract

“…19 Depression status may influence patients' ability to engage in smoking cessation. 6,7,9 Some evidence supports that smokers with current depression are less likely to succeed with smoking cessation compared to history positive patients.…”

mentioning

confidence: 99%

“…[3][4][5] Smokers with depression are more likely to relapse from a quit attempt, have higher nicotine dependence, suffer negative mood symptoms from withdrawal, and suffer greater smoking-related morbidity and mortality than the general population of smokers. [6][7][8][9][10][11][12] For the general population, effective smoking cessation interventions include nicotine replacement therapy (NRT), 13 antidepressants bupropion and nortriptyline, 14 nicotine receptor partial agonists varenicline, 15 and smoking cessation counseling. [16][17][18] Pharmacological and behavioral strategies increase the likelihood of successful quits attempt by 1.5 to 2 times compared to placebo or usual care.…”

mentioning

confidence: 99%

Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis

et al. 2011

View full text Add to dashboard Cite

OBJECTIVES:We conducted a systematic literature review of smoking cessation interventions for patients with histories of depressive disorders or current significant depressive symptoms. We examined the comparative effectiveness of smoking cessation strategies on abstinence rates, differential effects of cessation strategies by depression status (i.e., history positive vs. current depression), and differential effects by gender. DATA SOURCES: Peer-reviewed literature in MEDLINE, Embase, PsycINFO, and Cochrane Library. STUDY ELIGIBILITY CRITERIA, PARTICIPANTS, AND INTERVENTIONS: Randomized controlled trials or secondary analysis of RCT data comparing two or more smoking cessation interventions or intervention to control, and reporting cessation outcomes in adults with depression. STUDY APPRAISAL AND SYNTHESIS METHODS: Two trained researchers screened articles for inclusion. When possible, we estimated pooled risk ratios with 95% confidence intervals by using a random effects model with the Mantel-Haenszel method. We synthesized other studies qualitatively. We classified each intervention as antidepressants, nicotine replacement therapy (NRT), brief smoking cessation counseling, smoking cessation behavioral counseling, or behavioral mood management. RESULTS: We identified 16 unique RCTs, of which, only three trials recruited participants with current depression. Meta-analysis demonstrated a small, positive effect of adding behavioral mood management (RR = 1.41, 95% CI 1.01-1.96). All included antidepressant trials showed small, positive effects, but risk ratio summary was not significant (RR = 1.31, 95% CI 0.73-2.34). Three NRT trials demonstrated small, positive effects on smoking cessation rates. We found insufficient evidence to examine gender and depression status moderator effects. LIMITATIONS: Few RCTs exist that test smoking cessation interventions among adults with depression. To make meaningful comparisons, we created broad intervention categories that contained heterogeneity. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS:Few trials enrolled smokers with current depression. Most of data identified were from subgroup analyses of patients history-positive for depression. However, several promising interventions exist. Healthcare providers should consider encouraging their patients with significant depressive symptoms or depression histories to seek smoking cessation services that include NRT and behavioral mood management.

show abstract

Symptoms of depression and survival experience among three samples of smokers trying to quit.

Cited by 193 publications

References 25 publications

Diabetic Patients Who Smoke: Are They Different?

Diabetic Patients Who Smoke: Are They Different?

Weight concerns affect motivation to remain abstinent from smoking postpartum

Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis

Contact Info

Product

Resources

About